Incorporating Clinical Practice Guidelines and Quality Measures Into High-Quality Cost-Effective Care for Patients With Multiple Sclerosis

Alexander D. Rae-Grant, MD, FRCPC, FAAN Multiple Sclerosis and Other CNS Inflammatory Diseases p. 845-849 June 2019, Vol.25, No.3 doi: 10.1212/CON.0000000000000726
PRACTICE ISSUES
BROWSE ARTICLES
Article as PDF
-- Select an option --

This article presents a hypothetical case of a patient with multiple sclerosis (MS), reviewing the use of clinical practice guidelines and incorporation of quality measures into practice. Appropriate diagnosis of MS is important to avoid the cost and consequences of a misdiagnosis. Ensuring that treatment discussion occurs when a patient with MS is receptive is good clinical practice and a guideline recommendation from the American Academy of Neurology. Continuing dialogue about disease-modifying therapy and ongoing monitoring are important for patient care and improved outcomes. Ultimately, cost-effective care in MS relates to using appropriate medicines in patients with active MS, ensuring adherence, and careful monitoring.

Address correspondence to Dr Alexander D. Rae-Grant, 2723 Cranlyn Rd, Shaker Heights, Ohio 44122, raegranta@gmail.com.

RELATIONSHIP DISCLOSURE: Dr Rae-Grant serves as deputy editor for DynamedPlus.

UNLABELED USE OF PRODUCTS/INVESTIGATIONAL USE DISCLOSURE: Dr Rae-Grant reports no disclosure.

© 2019 American Academy of Neurology.